Biovie CMO Joseph Palumbo buys $10,460 in common stock
What it means
- What to watch: The headline hangs on one number ($10,460) — one data point is a snapshot, so the trailing trend is the context it needs.
- How the stock is trading: $BIVI -3.13% in the latest session.
- Timing: It arrived overnight — the change beside it belongs to a session that had already packed up and gone home. Market holidays are not detected.
Where the stock stands
$BIVI last changed hands at $1.24, -3.13% on the session, 67% below its 52-week high of $3.79 and 51% above its low of $0.82 — in the lower part of the range. Over the year it has ranged 362% from low to high: a very wide band; big swings are routine for this one, not news. These are latest-session quotes, not live prices — the live tape is on the $BIVI page.
The bigger picture
Healthcare stories turn on approvals, trial data and pricing: one FDA decision or trial readout can swing a single drugmaker hard, while drug-pricing policy moves the whole group at once. On Wook's supply-chain scanner, Health Care reads calm today — no unusual stress in the filings and disclosures it watches. The scanner equivalent of a quiet night shift.
Coming up
$BIVI earnings in 16 days. These were on the calendar before this story and are not caused by it.
What to watch next
The $BIVI page has the full chart, the filings and the valuation model behind every figure here. Want the facts without the spin? Read how two or three outlets frame the same story — where they agree is the news, where they differ is the angle. And Wook AI, up top, will happily do the math — how far $BIVI sits from its high, or how this week's coverage stacks up.
How this analysis was made
Investing.com published it, and Wook filed it under Healthcare & Pharma. No strongly worded term either way, so it reads neutral at low severity — a factual headline rather than a charged one. It was matched to $BIVI. It carried $10,460, shown as published and not recalculated. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Investing.com published this on August 29, 2026. $BIVI has moved -45.61% ($2.28 to $1.24). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.